Nentwich, M.M., and M.W. Ulbig. 2015. Diabetic retinopathy - ocular complications of diabetes mellitus. World Journal of Diabetes 6 (3): 489–499.
Article PubMed PubMed Central Google Scholar
Yau, J.W., S.L. Rogers, R. Kawasaki, E.L. Lamoureux, J.W. Kowalski, T. Bek, S.J. Chen, J.M. Dekker, A. Fletcher, J. Grauslund, S. Haffner, R.F. Hamman, M.K. Ikram, T. Kayama, B.E. Klein, R. Klein, S. Krishnaiah, K. Mayurasakorn, J.P. O’Hare, T.J. Orchard, M. Porta, M. Rema, M.S. Roy, T. Sharma, J. Shaw, H. Taylor, J.M. Tielsch, R. Varma, J.J. Wang, N. Wang, S. West, L. Xu, M. Yasuda, X. Zhang, P. Mitchell, T.Y. Wong, and G. Meta-analysis for eye disease study. 2012. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35 (3): 556–564.
Article PubMed PubMed Central Google Scholar
Simo, R., C. Hernandez, and R. European Consortium for the Early Treatment of Diabetic. 2014. Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives. Trends in Endocrinology and Metabolism 25 (1): 23–33.
Forrester, J.V., L. Kuffova, and M. Delibegovic. 2020. The role of inflammation in diabetic retinopathy. Frontiers in Immunology 11: 583687.
Article CAS PubMed PubMed Central Google Scholar
Vujosevic, S., and R. Simó. 2017. Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach. Invest Ophthalmol Vis Sci 58 (6): Bio68-bio75.
Singh, R., A. Barden, T. Mori, and L. Beilin. 2001. Advanced glycation end-products: A review. Diabetologia 44 (2): 129–146.
Article CAS PubMed Google Scholar
Ying, L., Y. Shen, Y. Zhang, Y. Wang, Y. Liu, J. Yin, Y. Wang, J. Yin, W. Zhu, Y. Bao, and J. Zhou. 2021. Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus. Diabetes Research and Clinical Practice 177: 108880.
Article CAS PubMed Google Scholar
Stitt, A.W. 2010. AGEs and diabetic retinopathy. Investigative Ophthalmology & Visual Science 51 (10): 4867–4874.
Tao, D., N. Ni, T. Zhang, C. Li, Q. Sun, L. Wang, and Y. Mei. 2019. Accumulation of advanced glycation end products potentiate human retinal capillary endothelial cells mediated diabetic retinopathy. Molecular Medicine Reports 20 (4): 3719–3727.
CAS PubMed PubMed Central Google Scholar
Del Rio-Hortega Bereciartu, J. 2020. Pio del Rio-Hortega: The revolution of Glia. Anatomical Record (Hoboken) 303 (5): 1232–1241.
Li, F., D. Jiang, and M.A. Samuel. 2019. Microglia in the developing retina. Neural Development 14 (1): 12.
Article PubMed PubMed Central Google Scholar
Karlstetter, M., R. Scholz, M. Rutar, W.T. Wong, J.M. Provis, and T. Langmann. 2015. Retinal microglia: Just bystander or target for therapy? Progress in Retinal and Eye Research 45: 30–57.
Sierra, A., F. de Castro, J. Del Río-Hortega, J. Rafael Iglesias-Rozas, M. Garrosa, and H. Kettenmann. 2016. The “Big-Bang” for modern glial biology: Translation and comments on Pío del Río-Hortega 1919 series of papers on microglia. Glia 64 (11): 1801–1840.
Orihuela, R., C.A. McPherson, and G.J. Harry. 2016. Microglial M1/M2 polarization and metabolic states. British Journal of Pharmacology 173 (4): 649–665.
Article CAS PubMed Google Scholar
Shi, H., X.L. Wang, H.F. Quan, L. Yan, X.Y. Pei, R. Wang, and X.D. Peng. 2019. Effects of betaine on LPS-stimulated activation of microglial M1/M2 phenotypes by suppressing TLR4/NF-kappaB pathways in N9 cells. Molecules 24 (2).
Moutray, T., J.R. Evans, N. Lois, D.J. Armstrong, T. Peto, and A. Azuara-Blanco. 2018. Different lasers and techniques for proliferative diabetic retinopathy. Cochrane Database Syst Rev 3 (3): Cd012314.
Zhao, M., Y. Sun, and Y. Jiang. 2020. Anti-VEGF therapy is not a magic bullet for diabetic retinopathy. Eye (London, England) 34 (4): 609–610.
Shi, M., Z.W. Liu, and F.S. Wang. 2011. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clinical and Experimental Immunology 164 (1): 1–8.
Article CAS PubMed PubMed Central Google Scholar
Shi, Y., Y. Wang, Q. Li, K. Liu, J. Hou, C. Shao, and Y. Wang. 2018. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nature Reviews Nephrology 14 (8): 493–507.
Article CAS PubMed Google Scholar
Kode, J.A., S. Mukherjee, M.V. Joglekar, and A.A. Hardikar. 2009. Mesenchymal stem cells: Immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11 (4): 377–391.
Article CAS PubMed Google Scholar
Song, H.B., S.Y. Park, J.H. Ko, J.W. Park, C.H. Yoon, D.H. Kim, J.H. Kim, M.K. Kim, R.H. Lee, D.J. Prockop, and J.Y. Oh. 2018. Mesenchymal stromal cells inhibit inflammatory lymphangiogenesis in the cornea by suppressing macrophage in a TSG-6-dependent manner. Molecular Therapy 26 (1): 162–172.
Agrawal, M., P.K. Rasiah, A. Bajwa, J. Rajasingh, and R. Gangaraju. 2021. Mesenchymal stem cell induced Foxp3(+) Tregs suppress effector T cells and protect against retinal ischemic injury. Cells 10 (11).
Andersson, U., H. Yang, and H. Harris. 2018. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Seminars in Immunology 38: 40–48.
Article CAS PubMed Google Scholar
Dai, W., T. Tang, Z. Dai, D. Shi, L. Mo, and Y. Zhang. 2020. Probing the mechanism of hepatotoxicity of hexabromocyclododecanes through toxicological network analysis. Environmental Science and Technology 54 (23): 15235–15245.
Article CAS PubMed Google Scholar
Pourrajab, F., M.B. Yazdi, M.B. Zarch, M.B. Zarch, and S. Hekmatimoghaddam. 2015. Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach. Mol Cell Ther 3: 4.
Article PubMed PubMed Central Google Scholar
Mendiola, A.S., R. Garza, S.M. Cardona, S.A. Mythen, S.A. Lira, K. Akassoglou, and A.E. Cardona. 2016. Fractalkine signaling attenuates perivascular clustering of microglia and fibrinogen leakage during systemic inflammation in mouse models of diabetic retinopathy. Frontiers in Cellular Neuroscience 10: 303.
van Hecke, M.V., J.M. Dekker, G. Nijpels, A.C. Moll, R.J. Heine, L.M. Bouter, B.C. Polak, and C.D. Stehouwer. 2005. Inflammation and endothelial dysfunction are associated with retinopathy: The Hoorn Study. Diabetologia 48 (7): 1300–1306.
Article CAS PubMed Google Scholar
Joussen, A.M., T. Murata, A. Tsujikawa, B. Kirchhof, S.E. Bursell, and A.P. Adamis. 2001. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. American Journal of Pathology 158 (1): 147–152.
Article CAS PubMed PubMed Central Google Scholar
Yun, J.H., S.W. Park, K.J. Kim, J.S. Bae, E.H. Lee, S.H. Paek, S.U. Kim, S. Ye, J.H. Kim, and C.H. Cho. 2017. Endothelial STAT3 activation increases vascular leakage through downregulating tight junction proteins: Implications for diabetic retinopathy. Journal of Cellular Physiology 232 (5): 1123–1134.
Article CAS PubMed Google Scholar
Li, S., R. Hua, Z. Jing, L. Huang, and L. Chen. 2022. Correlation between retinal microstructure detected by optical coherence tomography and best corrected visual acuity in diabetic retinopathy macular edema. Front Endocrinol (Lausanne) 13: 831909.
Yu, C., K. Yang, X. Meng, B. Cao, and F. Wang. 2020. Downregulation of long noncoding RNA MIAT in the retina of diabetic rats with tail-vein injection of human umbilical-cord mesenchymal stem cells. International Journal of Medical Sciences 17 (5): 591–598.
Article CAS PubMed PubMed Central Google Scholar
van Velthoven, C.T., R.A. Sheldon, A. Kavelaars, N. Derugin, Z.S. Vexler, H.L. Willemen, M. Maas, C.J. Heijnen, and D.M. Ferriero. 2013. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44 (5): 1426–1432.
Article PubMed PubMed Central Google Scholar
Tan, T.T., W.S. Toh, R.C. Lai, and S.K. Lim. 2022. Practical considerations in transforming MSC therapy for neurological diseases from cell to EV. Experimental Neurology 349: 113953.
Article CAS PubMed Google Scholar
Regmi, S., S. Pathak, J.O. Kim, C.S. Yong, and J.H. Jeong. 2019. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. European Journal of Cell Biology 98 (5–8): 151041.
Article CAS PubMed Google Scholar
Alvarado-Velez, M., S.F. Enam, N. Mehta, J.G. Lyon, M.C. LaPlaca, and R.V. Bellamkonda. 2021. Immuno-suppressive hydrogels enhance allogeneic MSC survival after transplantation in the injured brain. Biomaterials 266: 120419.
Article CAS PubMed Google Scholar
Ransohoff, R.M. 2016. A polarizing question: Do M1 and M2 microglia exist? Nature Neuroscience 19 (8): 987–991.
Article CAS PubMed Google Scholar
Paolicelli, R.C., A. Sierra, B. Stevens, M.E. Tremblay, A. Aguzzi, B. Ajami, I. Amit, E. Audinat, I. Bechmann, M. Bennett, F. Bennett, A. Bessis, K. Biber, S. Bilbo, M. Blurton-Jones, E. Boddeke, D. Brites, B. Brone, G.C. Brown, O. Butovsky, M.J. Carson, B. Castellano, M. Colonna, S.A. Cowley, C. Cunningham, D. Davalos, P.L. De Jager, B. de Strooper, A. Denes, B.J.L. Eggen, U. Eyo, E. Galea, S. Garel, F. Ginhoux, C.K. Glass, O. Gokce, D. Gomez-Nicola, B. Gonzalez, S. Gordon, M.B. Graeber, A.D. Greenhalgh, P. Gressens, M. Greter, D.H. Gutmann, C. Haass, M.T. Heneka, F.L. Heppner, S. Hong, D.A. Hume, S. Jung, H. Kettenmann, J. Kipnis, R. Koyama, G. Lemke, M. Lynch, A. Majewska, M. Malcangio, T. Malm, R. Mancuso, T. Masuda, M. Matteoli, B.W. McColl, V.E. Miron, A.V. Molofsky, M. Monje, E. Mracsko, A. Nadjar, J.J. Neher, U. Neniskyte, H. Neumann, M. Noda, B. Peng, F. Peri, V.H. Perry, P.G. Popovich, C. Pridans, J. Priller, M. Prinz, D. Ragozzino, R.M. Ransohoff, M.W. Salter, A. Schaefer, D.P. Schafer, M. Schwartz, M. Simons, C.J. Smith, W.J. Streit, T.L. Tay, L.H. Tsai, A. Verkhratsky, R. von Bernhardi, H. Wake, V. Wittamer, S.A. Wolf, L.J. Wu, and T. Wyss-Coray. 2022. Microglia states and nomenclature: A field at its crossroads. Neuron 110 (21): 3458–3483.
Article CAS PubMed PubMed Central Google Scholar
Ronaldson, P.T., and T.P. Davis
留言 (0)